Jo
Non verificato

Johnson & Johnson

Di cosa scriviamo

BiotecnologiaFarmaceuticaSaluteSanitàWeb e Social Network
27/04/2026
Web e Social Network
Eventi
Biotecnologia
Farmaceutica
Salute
Johnson & Johnson to Participate in the Bernstein’s 42nd Annual Strategic Decisions Conference
1.00
21/04/2026
Web e Social Network
Finanza
Eventi
Industria
Biotecnologia
Farmaceutica
Salute
Johnson & Johnson to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
1.00
21/04/2026
Industria
Salute
Attrezzature medico-sanitarie
Tecnica
Software
Sanità
Cardiologia
Johnson & Johnson Showcases CARTO-Powered Innovation, Including Debut of CARTOSOUND SONATA, to Advance Arrhythmia Care at HRS 2026
1.00
15/04/2026
Eventi
Fiere
Biotecnologia
Farmaceutica
Salute
Johnson & Johnson to Participate in the Bank of America 2026 Healthcare Conference
1.00
14/04/2026
Titoli e azioni
Biotecnologia
Farmaceutica
Salute
Johnson & Johnson Announces 64th Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 3.1%
1.00
14/04/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Johnson & Johnson reports Q1 2026 results, raises 2026 outlook
1.00
16/03/2026
Industria
Salute
Attrezzature medico-sanitarie
Medicina - Varie
Farmaceutica
Cardiologia
Biotecnologia
Johnson & Johnson Drives Innovation in Pulsed Field Ablation with Peru Launch
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0